Breast Cancer Research And Treatment

Breast Cancer Research And Treatment

乳腺癌研究和治疗

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Breast Cancer Research And Treatment》是由Springer US出版社于1981年创办的英文国际期刊(ISSN: 0167-6806,E-ISSN: 1573-7217),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCI、SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.2780...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比91.21%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在273篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Breast Cancer Research And Treatment审稿周期约为约1月。该刊近年未被列入国际预警名单,年发文量约273篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 273 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 158 / 333

52.7

学科:ONCOLOGY SCIE Q2 151 / 333

54.8

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 145 / 328

55.9

学科:ONCOLOGY SCIE Q2 160 / 328

51.37

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 142 / 322

56.1

学科:ONCOLOGY SCIE Q2 135 / 322

58.23

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.1 SJR:1.34 SNIP:1.161
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q2 108 / 428

74%

大类:Medicine 小类:Cancer Research Q2 95 / 233

59%

期刊发文

  • mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo (vol 136, pg 379, 2012

    Author: Zhang, Yue; Xu, Song; Lin, Jun; Yao, Guangyu; Han, Zelong; Liang, Bo; Zou, Zhenhong; Chen, Zhenguo; Song, Qiancheng; Dai, Yifan; Gao, Tianming; Liu, Anling; Bai, Xiaochun

    Journal: BREAST CANCER RESEARCH AND TREATMENT. 2026; Vol. 217, Issue 2, pp. -. DOI: 10.1007/s10549-026-07918-4

  • ESR1 polymorphisms were associated with aromatase inhibitors induced musculoskeletal symptoms in breast cancer patient

    Author: Jing, Feng; Jiang, Lingyun; Cao, Yuling; Tian, Maoting; Qiu, Jiajia; Tang, Lichen; Hu, Yan

    Journal: BREAST CANCER RESEARCH AND TREATMENT. 2026; Vol. 216, Issue 3, pp. -. DOI: 10.1007/s10549-026-07927-3

  • Cost-effectiveness analysis of Mepitel Film for prevention of acute radiation dermatitis in breast cancer: a Canadian healthcare perspectiv

    Author: Tse, Shirley S. W.; Wong, Henry C. Y.; Charbonneau, Flay; Cao, Jeffrey Q.; Hijal, Tarek; Kerba, Marc; Waddle, Mark R.; Lee, Shing Fung; Sonis, Stephen T.; Wolf, Julie Ryan; Van Den Hurk, Corina; Corbin, Kimberly; Marta, Gustavo N.; Wong, Cindy; Chan, Raymond J.; Herst, Patries M.; Hill, Rosemary; Chow, Edward; Kim, Hayeon

    Journal: BREAST CANCER RESEARCH AND TREATMENT. 2026; Vol. 216, Issue 1, pp. -. DOI: 10.1007/s10549-026-07920-w

  • TMEM205 promotes M2-like macrophage polarization and advances the progression of triple-negative breast cance

    Author: Zhang, Yining; Peng, Jing; Ma, Teng; Liu, Xiangping; Liu, Jiaxiu; Zhou, Quan; Wang, Haibo

    Journal: BREAST CANCER RESEARCH AND TREATMENT. 2026; Vol. 216, Issue 1, pp. -. DOI: 10.1007/s10549-026-07911-x

  • Fertility preservation in breast cancer patients: a systematic review and summary of current evidence and recommendation

    Author: Chen, Yaxin; Wang, Ruirui; Wu, Lei; Li, Jing; Yang, Mengyuan; Qi, Xin; Wang, Mei; Wang, Yanhong; Li, Qi

    Journal: BREAST CANCER RESEARCH AND TREATMENT. 2026; Vol. 215, Issue 3, pp. -. DOI: 10.1007/s10549-026-07901-z

  • Prognosis and endocrine therapy efficacy in early breast cancer with estrogen receptor low expressio

    Author: Liu, Sihua; Du, Beidi; Zhang, Mengmeng; Zhai, Duanyang; Zhao, Xutu; Shao, Nan; Kuang, Xiaying; Zhang, Yunjian; Shi, Yawei; Yu, Liang; Lin, Ying

    Journal: BREAST CANCER RESEARCH AND TREATMENT. 2026; Vol. 215, Issue 2, pp. -. DOI: 10.1007/s10549-025-07885-2

  • Risk of second non-breast primary cancer in Chinese breast cancer patients with germline BRCA1/2 pathogenic variant

    Author: Liu, Jiaming; Chu, Futao; Yao, Lu; Sun, Jie; Chen, Jiuan; Zhang, Juan; Xu, Ye; Xie, Yuntao

    Journal: BREAST CANCER RESEARCH AND TREATMENT. 2026; Vol. 215, Issue 2, pp. -. DOI: 10.1007/s10549-025-07886-1

  • Chronic skin toxicities in breast cancer survivors: a systematic review and meta-analysis of radiotherapy technique

    Author: Lee, Shing Fung; Wong, Henry C. Y.; Robijns, Jolien; Ciocon, Stephen Lowell B.; dos Reis, Paula Elaine Diniz; Sadeghi, Sarina; Al-Khaifi, Muna; Ogita, Mami; Chan, Adrian W.; Rembielak, Agata; Livesey, Daniel; Chong, Matthew; Liu, Zhihui Amy; Trombetta, Mark; Koh, Wee Yao; Leong, Yiat Horng; Marta, Gustavo N.; Bonomo, Pierluigi; Salvestrini, Viola; Vassiliou, Vassilios; Chopade, Pradnya; Patel, Partha; Wong, Cindy; Wolf, Julie Ryan; van den Hurk, Corina; Chan, Raymond J.; Jefford, Michael; Chow, Edward; Kwan, Jennifer Yin Yee

    Journal: BREAST CANCER RESEARCH AND TREATMENT. 2025; Vol. 212, Issue 1, pp. 1-12. DOI: 10.1007/s10549-025-07700-y